161 related articles for article (PubMed ID: 19337311)
1. The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.
Zhang Z; Qiu L; Wang M; Tong N; Li J; Zhang Z
Eur J Hum Genet; 2009 Oct; 17(10):1294-303. PubMed ID: 19337311
[TBL] [Abstract][Full Text] [Related]
2. The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.
Zhou L; Zhang G; Zhou X; Li J
Biomed Pharmacother; 2015 Feb; 69():208-13. PubMed ID: 25661359
[TBL] [Abstract][Full Text] [Related]
3. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
Xu L; Zhou X; Jiang F; Qiu MT; Zhang Z; Yin R; Xu L
PLoS One; 2013; 8(9):e74543. PubMed ID: 24086353
[TBL] [Abstract][Full Text] [Related]
4. Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.
Wang M; Wang Z; Wang XJ; Jin TB; Dai ZM; Kang HF; Guan HT; Ma XB; Liu XH; Dai ZJ
Drug Des Devel Ther; 2016; 10():2359-67. PubMed ID: 27524883
[TBL] [Abstract][Full Text] [Related]
5. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
[TBL] [Abstract][Full Text] [Related]
6. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
7. Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis.
Mohammadi A; Salehi M; Khanbabaei H; Sheikhesmaeili F; Tajik N; Alavian SM
Infect Genet Evol; 2019 Dec; 76():104003. PubMed ID: 31425784
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of the Association Between FAS Ligand and TRAIL Genetic Polymorphisms and Intervertebral Disc Degeneration Susceptibility in Chinese Han population.
Huang X; Zhang W; Shao Z
Spine (Phila Pa 1976); 2018 Nov; 43(22):1602-1608. PubMed ID: 29652777
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
Zhang W; Li C; Wang J; He C
Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
[TBL] [Abstract][Full Text] [Related]
11. Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.
Zhu A; Wang M; Zhou G; Zhang H; Liu R; Wang Y
Rheumatol Int; 2016 Jun; 36(6):807-18. PubMed ID: 26905515
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.
Wu S; Wang S; Fu Y; Tang W; Jin H; Meng Q; Zhang C; Cui M; Cao X; Li X; Zhang Z; Chen R
Int J Cancer; 2017 Feb; 140(4):756-763. PubMed ID: 27790710
[TBL] [Abstract][Full Text] [Related]
13. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
14. Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects.
Yu X; Li Y; Yu Y; Lei J; Wan G; Cao F
Onco Targets Ther; 2016; 9():2049-56. PubMed ID: 27103831
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms rs763110 in
Huang P; Wang CH; Zhuo LY; Xia XS; Yang S; Zhang JW; Fan HZ; Wu JJ; Yu R; Yue M; Zhang Y
Br J Biomed Sci; 2020 Jul; 77(3):112-117. PubMed ID: 32209020
[TBL] [Abstract][Full Text] [Related]
16. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk.
Zhang DF; Jiang GB; Qin CQ; Liu DX; Hu YJ; Zhou J; Niu YM
Medicine (Baltimore); 2018 Feb; 97(6):e9873. PubMed ID: 29419701
[TBL] [Abstract][Full Text] [Related]
18. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
[TBL] [Abstract][Full Text] [Related]
19. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
20. Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis.
Zhu J; Lu L; Cheng X; Xie R; Chen Z; Li Y; Lin G; Liu J; Yang Y
Tumour Biol; 2014 Jun; 35(6):5137-42. PubMed ID: 24619598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
